472
Views
6
CrossRef citations to date
0
Altmetric
Review

History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents

&
Pages 1143-1152 | Published online: 28 Dec 2022

References

  • ArcherGLAntimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devicesAntimicrob Agents Chemother1978143539708013
  • ArcherGLClimoMWAntimicrobial susceptibility of coagulase-negative staphylococciAntimicrob Agents Chemother199438223177840550
  • ArciolaCRCampocciaDAnYHPrevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implantsInt J Artif Organs20062939540116705608
  • AslamSTrautnerBWRamanathanVCombination of tige-cycline and N-acetylcycteine reduces biofilm-embedded bacteria on vascular cathetersAntimicrob Agents Chemother2007511556817220399
  • BayramABalciIPatterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in TurkeyBMC Infect Dis2006615517064415
  • Ben-AmiRNavon-VeneziaSSchwartzDErronous reporting of coagulase-negative staphylococci as kocuria spp. by the Vitek 2 systemJ Clin Microbiol20054314485015750130
  • BentleyDWHaqueRUMurphyRABiotyping, an epidemiological tool for coagulase-negative staphylococciAntimicrob Agents Chemother (Bethesda)196775494876094
  • BirnbaumDKellyMChowAWEpidemiologic typing systems for coagulase-negative staphylococciInfect Control Hosp Epidemiol199112319261865104
  • BisnoALMolecular aspects of bacterial colonizationInfect Control Hosp Epidemiol199516648578601686
  • BogdanovichTEdnieLMShapiroSAntistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporinAntimicrob Agents Chemother2005a494210916189100
  • BogdanovichTEselDKellyLMAntistaphylococcal activity of DX-619, a new des-f(6)-quinolone, compared to those of other agentsAntimicrob Agents Chemother2005b4933253316048943
  • Brötz-OesterheltHBeyerDKrollHPDysregulation of bacterial proteolytic machinery by a new class of antibioticsNat Med2005111827
  • CaierãoJSupertiSKiasCAGAutomated systems in the identification and determination of methicillin resistance among coagulase negative staphylococciMem Inst Oswaldo Cruz20061012778016862322
  • CercaNMartinsSCercaFComparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetryJ Antimicrob Chemother200556331615980094
  • CostaSFMiceliMHAnaissieEJMucosa or skin as source of coagulase-negative staphylococcal bacteraemiaLancet Infect Dis200442788615120344
  • CritchleyIABlosser-MiddletonRSJonesMEBaseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000–2001Antimicrob Agents Chemother20034716899312709341
  • CuevasOCercenadoEVindelAEvolution of the antimicrobial resistance of staphylococcus spp. In Spain: five nationwide prevalence studies, 1986 to 2002Antimicrob Agents Chemother2004484240515504847
  • DavidsonRJLowDEYuVLMeriganTCStaphylococcus epidermidis and other coagulase-negative staphylococciAntimicrobial Therapy and Vaccines1998
  • DiekemaDJPfallerMASchmitzFJSurvey of infections due to staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY antimicrobial surveillance pro, 1997–1999Clin Infect Dis200132S1143211320452
  • FowlerVGJrBoucherHWCoreyGRDaptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med20063556536516914701
  • FridkinSKStewardCDEdwardsJRSurveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE Phase 2Clin Infect Dis1999292455210476720
  • FrankKLReichertEJPiperKEPatelR In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdenensis clinical isolatesAntimicrob Agents Chemother2007518889517158933
  • FriedmanLAlderJDSilvermanJAGenetic chanages that correlate with reduced susceptibility to daptomycin in Staphylococcus aureusAntimicrob Agents Chemother20065021374516723576
  • FritscheTRRennieRPGoldsteinBPComparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using Gram-positive organismsJ Clin Microbiol20064429889016891523
  • GalesACJonesRNAndradeSSIn vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin AmericaBraz J Infect Dis200593485616410885
  • GanderSKinnairdAFinchRTelavancin: in vitro activity against staphylococci in a biofilm modelJ Antimicrob Chemother2005563374315972312
  • Gaudioso de AlloriMCJureMARomeroCAntimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative staphylococcus strainsBiol Pharm Bull2006291592616880610
  • HanssenAMKjeldsenGSollidJULocal variants of staphylococcal cassette chromosome mec in sporadic methicillin-resistant staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci: evidence of horizontal gene transferAntimicrob Agents Chemother2004482859614693553
  • HardyDAmsterdamDMandellLAComparative in vitro activities of ciprofloxacin, gemifloxacin,grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocciAntimicrob Agents Chemother200040802510681365
  • HussainZStoakesLLanniganREvaluation of screening and commercial methods for Detection of methicillin resistance in coagulase-negative staphylococciJ Clin Microbiol19983627349431964
  • JohnJFCosaminoBHarvinASpecies prevalence of coagulase-negative staphylococci at two departments of veterans affairs medical centers200612th International Symposium on Staphylococcal Infections and StaphylococciSeptember 4–6, 2006Maestricht, The Netherlands
  • JonesMEKarlowskyJADraghiDCEpidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapyInt J Antimicrob Agents2003224061914522104
  • KarlowskyJALaingNMBaudryTIn vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis Antimicrob Agents Chemother2007In press
  • KeysTFHewittWLEndocarditis due to micrococci and Staphylococcus epidermidisArch Intern Med1973132216204489733
  • KhardoriNWongENguyenHEffect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonizationJ Infect Dis1991164108131829103
  • KingAPhillipsIKanigaKComparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteriaJ Antimicrob Chemother20045379780315028667
  • KloosWEBannermanTLUpdate on clinical significance of coagulase-negative staphylococciClin Microbiol Rev19947117408118787
  • KloosWEGeorgeCGIdentification of Staphylococcus species and subspecies with the MicroScan Pos ID and Rapid Pos ID panel systemsJ Clin Microbiol199129738441890175
  • KloosWEJorgensenJHLannetteEHBallowsAHauslerWJJrStaphylococciManual of Clinical Microbiology19854Washington D.C.American Society for Microbiology1457
  • KloosWESchleiferKHSimplified scheme for routine identification of human Staphylococcus speciesJ Clin Microbiol19751828170303
  • KoksalFYasarHSamastiMAntibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in TurkeyMicrobiol Res2007In press
  • LaPlanteKLRybakMJClinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecyclineDiagn Microbiol Infect Dis2004501253015474322
  • LigozziMBerniniCGraziaMEvaluation of the VITEK 2 system for identification and amtimicrobial susceptibility testing of medically relevant Gram-positive cocciJ Clin Microbiol2002401681611980942
  • LinGCreditoKEdnieLApplebaumPCAntistaphylococcal activity of dalbavancin, an experimental glycopeptidesAntimicrob Agents Chemother200549770215673763
  • MackDDaviesAPHarrisLGMicrobial interactions in Staphylococcus epidermidis biofilmsAnal Bioanal Chem200638739940816955256
  • MongkolrattanothaiKBoyleSMurphyTVNovel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagf genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureusAntimicrob Agents Chemother20044818233615105141
  • MushtaqSWarnerMJohnsonAPActivity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methodsJ Antimicrob Chemother2004546172015321983
  • NoskinGASiddiquiFStosorV In vitro activities of linezolid against important Gram-positive bacterial pathogens including vancomycin-resistant enterococciAntimicrob Agents Chemother19994320596210428937
  • NotoMJArcherGLA subset of Staphylococcus aureus strains harboring staphylococcal cassette chromosome mec (SCCmec) type IV is deficient in CcrAB-mediated SCCmec excisionAntimicrob Agents Chemother2006502782816870772
  • PankuchGAAppelbaumPCPostantibiotic effect of ceftibiprole against 12 Gram-positive organismsAntimicrob Agents Chemother2006503956817065631
  • ParagioudakiMStamouliVKolonitsiouFIntravenous catheter infections associated with bacteraemia: a 2-year study in a university hospitalClin Microbiol Infect200410431515113321
  • PatelRBiofilms and antimicrobial resistanceClin Orthop Relat Res200543741716056024
  • PerlTMRhombergPRBaleMJComparison of identification systems for Staphylococcus epidermidis and other coagulase-negative staphylococcus SpeciesDiagn Microbiol Infect Dis19941815157924206
  • PetersenPJBradfordPAWeissWJIn vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus Antimicrob Agents Chemother200246259560112121938
  • PinnaAZanettiSSotgiuMIdentification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infectionsBr J Ophthalmol199983771310381660
  • PotoskiBAAdamsJClarkeLEpidemiological profile of linezolid-resistant coagulase-negative staphylococciClin Infect Dis2006431657116779742
  • RecchiaFMBusbeeBGPearlmanRBChanging trends in the microbiologic aspects of postcataract endophthalmitisArch Ophthalmol20051233214615767473
  • RossJEAndereggTRSaderHSTrends in linezolid susceptibility pattens in 2002: report from worldwide Zyvox Annual Appraisal of Potency and Spectrum ProgramDiagn Microbiol Infect Dis20055253815878443
  • RuppMEArcherGLCoagulase-negative staphylococci: pathogens associated with medical progressClin Infect Dis199419231437986894
  • RuppMEHamerKEEffect of subinhibitory concentrations of vancomycin, cefazolin, ofloxacin, L-ofloxacin and D-ofloxacin on adherence to intravascular catheters and biofilm formation by Staphylococcus epidermidisJ Antimicrob Chemother1998411551619533456
  • SaderHSJonesRNStilwellMGTigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continentsDiagn Microbiol Infect Dis200552181616105562
  • SaginurRSt DenisMFerrisWMultiple combination bactericidal testing of staphylococcal biofilms from implant-associated infectionsAntimicrob Agents Chemother200650556116377667
  • SahmDFMarsilioMKPiazzaGAntimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the surveillance network database-USAClin Infect Dis1999292596310476722
  • SanchesSMatoRLencastreHDPatterns of multidrug resistance among methicillin-resistant Hospital Isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998Microb Drug Resist2000619921111144420
  • SchabergDrCulverDHGaynesRPMajor trends in the microbial etiology of nosocomial infectionAm J Med199191S725
  • SchoenbaumSCGardnerPShillitoJInfections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapyJ Infect Dis1975131543521127260
  • SherertzRJBogerMSCollinsCAComparative in vitro efficacies of various catheter lock solutionsAntimicrob Agents Chemother2006501865816641463
  • ShinabargerDMechanism of action of the oxazolidinone antibacterial agentsExpert Opin Investg Drugs199981195202
  • SilvermanJAOliverNAndrewTResistance studies with daptomycinAntimicrob Agents Chemother200145179980211353628
  • SpiliopoulouISantosSIBartzavaliCApplication of molecular typing methods to characterize nosocomial coagulase-negative staphylococci collected in a Greek hospital during a three-year period (1998–2000)Microb Drug Resist200392738212959406
  • StryjewskiMEChuVHO’RiordayWDTelavacin veruss standard therapy for treatment of complicated skin and skin structure infections caused by Gram-positive bacteria: FAST studyAntimicrob Agents Chemother200650862716495243
  • SutherlandRRolinsonGNCharacteristics of methicillin resistant staphylococciJ Bacteriol1964878879914137628
  • TristanAFischettiVABiology and pathogenicity of staphylococci other than Staphylococcus aureus and Staphylococcus epidermidis Gram-Positive Pathogens20062Washington, D.C.ASM Press57286
  • von EiffCPetersGHeilmannCPathogenesis of infections due to coagulase-negative staphylococciLancet Infect Dis200226778512409048
  • VuongCChristianeGSomervilleGAQuorum-sensing control of biofilm factors in Staphylococcus epidermidis J Infect Dis20031887061812934187
  • WiderströmMMonsenTKarlssonCMolecular epidemiology of methicillin-resistant coagulase-negative staphylococci in a Swedish county hospital: evidence of intro- and interhospital clonal spreadJ Hosp Infect2006641778316911846
  • XuLLiHVuongCRole of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis Infect Immun2006744889616369005